Helixor P (Liquid Extract From Viscum Album Subsp. Austriacum Var Pinus Sylvestris (1:20), Extraction Solvents:)

Helixor P is used in clinical practice primarily as an adjunctive therapy in certain oncological and supportive care settings, although its specific indications are not formally approved in many jurisdictions.

• As an adjunct to conventional cancer treatments in patients receiving chemotherapy or radiotherapy.
• To support quality‑of‑life measures such as fatigue, appetite, and emotional well‑being during cancer care.
• In integrative oncology programs that incorporate herbal preparations alongside standard therapies.
• For investigational use within clinical trials evaluating mistletoe extracts in oncology.
• As a supportive agent in palliative care to potentially improve symptom management.

Reported adverse reactions to Helixor P are generally mild, but rare serious events have been documented.

Common

• Local redness, swelling, or pain at the injection site.
• Transient fever, chills, or flu‑like symptoms.
• Mild headache or fatigue.
• Nausea or mild gastrointestinal discomfort.

Serious

• Allergic reactions such as urticaria, angioedema, or anaphylaxis.
• Severe hypotension or cardiovascular instability.
• Hepatic enzyme elevation in isolated cases.

When prescribing Helixor P, clinicians should consider several precautionary measures to ensure patient safety.

• Assess for known hypersensitivity to mistletoe extracts before initiating therapy.
• Monitor vital signs and injection‑site reactions after each administration.
• Use caution in patients with autoimmune disorders or immunosuppression.
• Evaluate liver function periodically, especially in long‑term use.
• Avoid use during pregnancy or lactation until safety data are available.
• Consider dose adjustments or discontinuation if severe adverse reactions occur.

Helixor P may interact with other medications, and awareness of potential interactions helps prevent complications.

Avoid

• Concurrent use with immunosuppressive agents such as high‑dose corticosteroids or biologics without close monitoring.
• Simultaneous administration of other herbal preparations that have overlapping immunomodulatory effects.

Use with caution

• Chemotherapeutic agents, as mistletoe extracts may alter immune response or toxicity profiles.
• Anticoagulants, because injection‑site inflammation could affect bleeding risk.
• Antihypertensive drugs, if severe hypotensive reactions occur.